Dublin, April 17, 2017 -- Research and Markets has announced the addition of the "Infusion Pumps and Devices: Technologies and Global Markets" report to their offering.
The global market for infusion pumps and devices reached $18.5 billion in 2015. The market should reach $19.6 billion in 2016 and nearly $25.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.
This report focuses on the global market of infusion devices and applications as medical equipment. This report focuses on the global market of infusion pumps and devices, providing an updated review including basic design and its applications in various arenas of biomedical and healthcare sectors. The report covers the total market, which includes two broad categories: general infusion pumps and devices, and specialty infusion pumps and devices.
General pumps and devices are categorized into large volume infusion pumps, ambulatory and disposable pumps, syringe infusion and chemotherapy pumps. Specialty pumps are categorized as enteral, patient-controlled analgesics (PCA), insulin pumps and implantable pumps. The report also covers the market for infusion devices by the end user, with emphasis on the usage of infusion pumps and devices in therapeutic categories and various disease sectors.
The end users for infusion devices considered in the report are diabetes, anesthesia and analgesia, oncology and blood disorders, nutrition, other applications such as treatment of diseases like congestive heart failure, Parkinson's disease, hemophilia and immune deficiencies.
The key market players include Animas Corp., Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG, I-Flow Corp., Hospira Inc., Insulet Corp., Medtronic, Moog Inc. and Smiths Medical.
Key Topics Covered:
1: Introduction
- Study Objectives
- Reasons For Doing This Study
- Contributions Of The Study And For Whom
- Scope Of The Study
- Methodology
- Information Sources
2: Executive Summary - Complimentary
3: Overview
- Definitions
- Introduction
- Advantages And Disadvantages Of Infusion Devices
- History Of Infusion Pumps And Devices
- Classification Of Infusion Pumps And Devices
- Infusion Pump Associated Hazards And Problems
- Future Of Infusion Pumps And Devices
4: Regulatory Aspects
- New Products Approved From 2013 To 2016
- Fda Recalls And Safety Alerts
5: New Developments
- New Products And Developments
- Awards For Infusion Pumps And Devices
6: Market Analysis
- Market By Type
- Market By Region
7: Industry Structure
- General Infusion Pumps And Devices
- Specialty Infusion Pumps And Devices
8: Market By Application
- Market By Application Of Global Infusion Pumps And Devices
- General Infusion Pumps And Devices
- Specialty Infusion Pumps And Devices
9: Patent Analysis
- Patents By Year
- Patents By Type
- Patents By Company
- Patents By Country
- Patents By Assignee
10: Current Situation
- Factors Affecting The Infusion Pumps And Devices Market
- Mergers And Acquisitions: Future Perspective
11: Company Profiles
- Animas Corp.
- Baxter International
- B. Braun Melsungen AG
- BD Biosciences
- Carefusion
- Cequr S.A.
- Codman & Shurtleff Inc.
- Covidien Plc
- Debiotech
- Flowonix Medical Inc.
- Fresenius Kabi Ag
- Halyard Health Inc.
- Hospira Inc.
- I-Flow Corp.
- Insulet Corp.
- Intrapump Infusion Systems
- Iradimed Corp.
- Medtronic Inc.
- Micrel Medical Devices
- MOOG Inc.
- Nipro Corp.
- Novo Nordisk A/S
- Pfizer Inc.
- Smiths Medical
- Sooil Development
- Summit Medical Products Inc.
- Tandem Diabetes Care Inc.
- Terumo Corp.
- Valeritas Inc.
- Zyno Medical Llc
12: Appendix I-Abbreviations
For more information about this report visit http://www.researchandmarkets.com/research/bj4v52/infusion_pumps
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables , Needles and Syringes


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



